CYP2C19 and diabetes mellitus: In the multiplicative model of our logistic regression analysis, a male patient with diabetes and peripheral arterial disease would have an about 20 times elevated baseline risk, and the presence of a CYP2C19 LoF variant would further increase this to a 40 times elevated relative risk of thrombotic events under clopidogrel.